Log in Subscribe Join Grass Roots Action

Draft Industry Guidance Released on Evaluating Effectiveness of New Animal Drugs to Reduce STEC in Cattle

Wednesday, February 25, 2015

(North American Meat Institute)

FDA's Center for Veterinary Medicine (CVM) released a draft guidance document providing recommendations to industry regarding ways to evaluate the effectiveness of new animal drugs to reduce pathogenic Shiga toxin-producing E. coli in cattle. The draft guidance provides recommendations on study design and describes criteria that CVM thinks are most appropriate to evaluate the effectiveness of new animal drugs.

 share on facebook  share on twitter